Omnipres AM Tablet is a combination antihypertensive medication containing Olmesartan Medoxomil 20mg and Amlodipine 5mg, indicated for the treatment of hypertension. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, resulting in vasodilation and a reduction in aldosterone secretion, thereby lowering blood pressure. Amlodipine is a dihydropyridine calcium channel blocker that inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, leading to peripheral arterial vasodilation and decreased systemic vascular resistance. The combined action of these two agents provides complementary mechanisms to achieve effective blood pressure control, reducing the risk of cardiovascular events such as stroke and myocardial infarction. Omnipres AM is typically prescribed when monotherapy is insufficient to achieve target blood pressure levels. It is important to administer the tablet once daily, with or without food, as directed by a healthcare professional. Patients should be monitored for potential side effects including dizziness, peripheral edema, hypotension, and renal function alterations. Caution is advised in patients with hepatic or renal impairment, and contraindications include hypersensitivity to any component, pregnancy, and severe hypotension. Regular follow-up is essential to optimize therapy and ensure patient safety.